Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

Cannabis Use Disorder Treatment Study

NCT04567394

Conditions
Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe, +10 more
Locations
  • Colorado State University Fort Collins, Colorado, United States
  • University of Tennessee Knoxvile Knoxville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT03007147

Conditions
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +24 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 226 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

NCT06752850

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Classic Hemophilia, +24 more
Locations
  • Sobi Investigational Site Milan, Italy
  • Sobi Investigational Site Naples, Italy
  • Sobi Investigational Site Rozzano, Italy
  • Sobi Investigational Site Oslo, Norway
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

NCT01849263

Conditions
Grade 3a Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04384484

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Redlands Community Hospital Redlands, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 144 locations
View Trial Details

Related conditions